đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The goal of this investigator-initiated single-site clinical trial is to co...
Status
Recruiting
Location
Main Line Health
Start Date
2024-08-15
Trial ID
NCT06439524
Treatments Being Tested
The objectives of this randomized withdrawal study are to evaluate the long...
Status
Completed
Location
Birmingham
Start Date
2018-10-16
Trial ID
NCT03751124
Treatments Being Tested
The purpose of this study is to determine the benefit of relugolix 40 milli...
Status
Completed
Location
Birmingham
Start Date
2017-06-14
Trial ID
NCT03103087
This study is being conducted to assess the safety and tolerability of relu...
Status
Completed
Location
Urological Associates of Southern Arizona, P.C.
Start Date
2021-02-18
Trial ID
NCT04666129
Treatments Being Tested
Researchers leading this study hope to learn about the safety of combining ...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2023-02-13
Trial ID
NCT05679388
Treatments Being Tested
This was a randomized, open-label, repeat dose study of once daily relugoli...
Status
Completed
Location
Clinical Study Site
Start Date
2016-06-16
Trial ID
NCT04978688
The mechanisms underlying variable efficacy of Relugolix-Combination Therap...
Status
Withdrawn
Location
NorthShore University HealthSystem
Start Date
2024-06-01
Trial ID
NCT06279195
Treatments Being Tested
This is a nonrandomized, open-label, fixed-sequence, 2-arm study designed t...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02093390
Treatments Being Tested
This is a two-part, open-label, fixed-sequence, two-period crossover drug i...
Status
Completed
Location
Clinical Pharmacology of Miami, An Evolution Research Group Portfolio Company
Start Date
2021-01-06
Trial ID
NCT04714554
Treatments Being Tested
The purpose of this study is to determine the benefit and safety of relugol...
Status
Completed
Location
Andalusia
Start Date
2017-11-01
Trial ID
NCT03204331